SCHEMBL30189633

SCHEMBL30189633

N=C(N)c1ccncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14755756 1.00
Hydrochloric Acid SCHEMBL16040200 0.98 P2RX7 (0.50)
SCHEMBL27599895 0.80
SCHEMBL16791674 0.78 P2RX7 (0.49)
SCHEMBL28562684 0.77
SCHEMBL220487 0.77
SCHEMBL27668397 0.77
SCHEMBL26081630 0.77
SCHEMBL29564726 0.77
SCHEMBL15500957 0.77 P2RX7 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120035583-A PAN-KRAS inhibitors 米拉蒂治疗股份有限公司 2025-05-23 CN disclosed
US-11986471-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2024-05-21 US disclosed
US-20230060499-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2023-03-02 US disclosed
US-11542256-B2 Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors ANGION BIOMEDICA CORP. (US) 2023-01-03 US disclosed